Patient journey mapping is a valuable process for pharmaceutical companies to gain a deep understanding of a patient's experience and interactions with their products and healthcare services. This enables pharma companies to better meet patient needs, improve engagement, and develop more patient-centric solutions.
This approach also helps to improve communication between patients and healthcare organizations. By understanding where, when, and how patients seek information, pharmaceutical organizations can ensure that communication is timely, relevant, and supportive. 

Most of the leading pharma companies have their patient support programs up & running, particularly in the chronic segments, therefore mapping the effectiveness of the same can help make the offerings sharper & more effective. In this edition of the newsletter, our focus is on benchmarking the Patient Journey Mapping by 1Lattice.

Patient journey mapping can help pharmaceutical organizations allocate resources more effectively. By identifying the key touchpoints in a patient's journey, organizations can allocate resources to the areas that have the greatest impact on patient outcomes. A typical patient journey goes through the continuum of the initial awareness of a medical condition through diagnosis, treatment, and long-term management.

Segmenting the patients into different personas based on factors like medical conditions, demographics, and treatment history is helpful for a better understanding of the patient journey ecosystem. Each persona may have a unique journey. Let us understand further with two diverse yet chronic disease segments of Breast Cancer and Chronic Kidney Disease (CKD) as examples.

In the case of a breast cancer patient, there are diverse stakeholders involved such as patients, HCPs & diagnostic service providers. Mapping of emotional and functional aspects at each touchpoint such as how patients feel, what challenges they face, and what information or support they need at each stage.

Similarly for Chronic Kidney Disease (CKD) patients identifying pain points where patients face challenges or frustrations and areas where opportunities exist for improving patient experience by pharma companies can enhance the outcomes of patient support programs.

With the 1Lattice 1Sense comprehensive benchmarking suite, we can map the patient journey comprehensively. Our data-driven approach & robust methodology allow pharmaceutical organizations to make informed decisions about resource allocation, service improvements, and patient engagement strategies.

Measuring the Net Promotor Score (NPS) at the patient level provides pharma companies with a good sense of the amount of trust patients have in their brand. Overall, patient journey mapping is a valuable tool for pharmaceutical organizations to understand the patient experience, improve support services, and ultimately enhance patient outcomes and satisfaction.